Corporate News 09-Aug-24
Spandana Sphoorty Financial approves NCD issuance of Rs 50 cr
Spandana Sphoorty Financial has approved the issuance of 5000 Senior, Secured, Rated, Listed, Redeemable, Taxable, Transferable, Non Convertible Debentures of Rs 1 lakh each at par on private placement basis. The deemed date of allotment is 14 August 2024.
Previous News
Spandana Sphoorty Financial allots NCDs aggregating Rs 150 cr
( Corporate News - 02-Aug-24 18:17 )
India Ratings downgrades ratings of Spandana Sphoorty to 'A-' with 'negative' outlook
( Hot Pursuit - 11-Jun-25 14:39 )
Spandana Sphoorty Financial schedules board meeting
( Corporate News - 23-Aug-24 12:24 )
Spandana Sphoorty Financial schedules board meeting
( Corporate News - 21-Jan-25 11:10 )
Spandana Sphoorty Financial
( Analyst Meet / AGM - Conference Call 23-May-24 13:14 )
Spandana Sphoorty board to mull NCD issue on Aug 27
( Hot Pursuit - 23-Aug-24 08:54 )
Spandana Sphoorty board approves fund raising proposal
( Hot Pursuit - 30-Aug-23 12:59 )
Spandana Sphoorty Financial Ltd leads gainers in 'A' group
( Hot Pursuit - 21-Apr-25 12:00 )
Spandana Sphoorty Financial to conduct board meeting
( Corporate News - 12-Jan-24 12:33 )
Spandana Sphoorty Financial approves NCD issuance of Rs 100 cr
( Corporate News - 15-Mar-24 15:46 )
Spandana Sphoorty Financial allots NCDs aggregating Rs 100 cr
( Corporate News - 18-Dec-23 13:37 )
Other Stories
Board of Arkade Developers approves acquisition of Filmistan
03-Jul-25 11:06
FAST India partners with Indegene to accelerate biotech innovation in India
03-Jul-25 11:01
LMW schedules board meeting
03-Jul-25 09:15
Julien Agro Infratech announces board meeting date
03-Jul-25 09:15
Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
03-Jul-25 09:15
Shriram Asset Mgt. Company schedules AGM
03-Jul-25 09:14
Ideaforge Technology to convene AGM
03-Jul-25 09:14
D-Link (India) to announce Quarterly Result
03-Jul-25 09:14
Tuni Textile Mills to conduct board meeting
03-Jul-25 09:14
Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
03-Jul-25 09:12
Back
Top
